Jlang, I agree completely with your belief in D
Post# of 148188
(Total Views: 506)
Posted On: 10/28/2021 8:56:00 AM
Jlang,
I agree completely with your belief in Dr Recknor. His work is supported by the work of Dr Gold identifying EBV reactivation in PASC/long haulers.
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
https://www.mdpi.com/2076-0817/10/6/763
“ We found the prevalence of long COVID symptoms to be 30.3% (56/185), which included 4 initially asymptomatic COVID-19 patients who later developed long COVID symptoms. Next, we found that 66.7% (20/30) of long COVID subjects versus 10% (2/20) of control subjects in our primary study group were positive for EBV reactivation based on positive titers for EBV early antigen-diffuse (EA-D) IgG or EBV viral capsid antigen (VCA) IgM. The difference was significant (p < 0.001, Fisher’s exact test). A similar ratio was observed in a secondary group of 18 subjects 21–90 days after testing positive for COVID-19, indicating reactivation may occur soon after or concurrently with COVID-19 infection. These findings suggest that many long COVID symptoms may not be a direct result of the SARS-CoV-2 virus but may be the result of COVID-19 inflammation-induced EBV reactivation”
I agree completely with your belief in Dr Recknor. His work is supported by the work of Dr Gold identifying EBV reactivation in PASC/long haulers.
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
https://www.mdpi.com/2076-0817/10/6/763
“ We found the prevalence of long COVID symptoms to be 30.3% (56/185), which included 4 initially asymptomatic COVID-19 patients who later developed long COVID symptoms. Next, we found that 66.7% (20/30) of long COVID subjects versus 10% (2/20) of control subjects in our primary study group were positive for EBV reactivation based on positive titers for EBV early antigen-diffuse (EA-D) IgG or EBV viral capsid antigen (VCA) IgM. The difference was significant (p < 0.001, Fisher’s exact test). A similar ratio was observed in a secondary group of 18 subjects 21–90 days after testing positive for COVID-19, indicating reactivation may occur soon after or concurrently with COVID-19 infection. These findings suggest that many long COVID symptoms may not be a direct result of the SARS-CoV-2 virus but may be the result of COVID-19 inflammation-induced EBV reactivation”
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼